Heart Disease News and Research

Latest Heart Disease News and Research

Anticoagulation after primary PCI does not prevent adverse outcomes in STEMI patients

Anticoagulation after primary PCI does not prevent adverse outcomes in STEMI patients

Early initiation of dapagliflozin in acute decompensated heart failure does not improve diuretic efficiency

Early initiation of dapagliflozin in acute decompensated heart failure does not improve diuretic efficiency

Trial finds no benefit of minimizing atrial pacing in patients with sinus node dysfunction

Trial finds no benefit of minimizing atrial pacing in patients with sinus node dysfunction

SGLT2 inhibitors do not reduce 28-day mortality in hospitalized COVID-19 patients

SGLT2 inhibitors do not reduce 28-day mortality in hospitalized COVID-19 patients

Inorganic nitrate reduces contrast-induced nephropathy in high-risk patients

Inorganic nitrate reduces contrast-induced nephropathy in high-risk patients

Longer duration of anticoagulation therapy benefits cancer patients with isolated distal DVT

Longer duration of anticoagulation therapy benefits cancer patients with isolated distal DVT

An update on the health benefits of olive oil

An update on the health benefits of olive oil

How can different diets combined with salt restriction alleviate high blood pressure and hypertension?

How can different diets combined with salt restriction alleviate high blood pressure and hypertension?

Can childhood traumas affect pandemic resilience? Study investigates connection between adverse experiences and mental, physical health during COVID-19

Can childhood traumas affect pandemic resilience? Study investigates connection between adverse experiences and mental, physical health during COVID-19

Inflammatory diets raise dementia and Alzheimer's risk

Inflammatory diets raise dementia and Alzheimer's risk

OCT-guided PCI does not reduce target vessel failure in complex patients, but improves safety

OCT-guided PCI does not reduce target vessel failure in complex patients, but improves safety

Unlocking ACE2: The enzyme that links COVID-19, heart disease, and diabetes

Unlocking ACE2: The enzyme that links COVID-19, heart disease, and diabetes

Study highlights the economic burden of cardiovascular diseases in the European Union

Study highlights the economic burden of cardiovascular diseases in the European Union

Trial addresses the optimal timing for complete revascularization of patients with STEMI and multivessel disease

Trial addresses the optimal timing for complete revascularization of patients with STEMI and multivessel disease

ECLS does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock

ECLS does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock

Fat-filled lipid droplets may be a potential threat to cell's nucleus

Fat-filled lipid droplets may be a potential threat to cell's nucleus

Pulsed field ablation safe, effective for the treatment of paroxysmal atrial fibrillation

Pulsed field ablation safe, effective for the treatment of paroxysmal atrial fibrillation

Study shows efficacy and safety of OCT-guided strategy for percutaneous coronary intervention

Study shows efficacy and safety of OCT-guided strategy for percutaneous coronary intervention

Acoramidis shows potential to be effective, safe treatment for transthyretin amyloid cardiomyopathy

Acoramidis shows potential to be effective, safe treatment for transthyretin amyloid cardiomyopathy

Switching to NOACs in frail elderly patients with atrial fibrillation increases bleeding risk

Switching to NOACs in frail elderly patients with atrial fibrillation increases bleeding risk

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.